Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exicure, Inc. - Common Stock (NQ:XCUR)

12.50 +0.10 (+0.81%)
Streaming Delayed Price Updated: 12:41 PM EDT, Mar 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Exicure, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
EXICURE SHAREHOLDER ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
EXICURE SHAREHOLDER ALERT
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ExicureTo Contact Him Directly To Discuss Their Options 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Exicure, Inc. Reports Third Quarter 2021 Financial Results and Corporate Progress
From Exicure, Inc.
Via Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
EXICURE SHAREHOLDER ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Exicure, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation – XCUR
From The Rosen Law Firm, P.A.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
EXICURE INVESTOR ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
The Law Offices of Frank R. Cruz Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Law Offices of Frank R. Cruz
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Exicure Files Form 12b-25
From Exicure, Inc.
Via Business Wire
Exicure to Present at Upcoming Scientific Conferences
From Exicure, Inc.
Via Business Wire
Exicure to Present at Upcoming Scientific Conferences
From Exicure, Inc.
Via Business Wire
Exicure to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
From Exicure, Inc.
Via Business Wire
Exicure to Present at the Benzinga Healthcare Small Cap Conference
From Exicure, Inc.
Via Business Wire
Exicure to Participate in Upcoming Scientific Conferences
From Exicure, Inc.
Via Business Wire
Exicure to Participate in Upcoming Investor Conferences
From Exicure, Inc.
Via Business Wire
Exicure, Inc. Reports Second Quarter 2021 Financial Results and Corporate Progress
From Exicure, Inc.
Via Business Wire
Exicure Provides Interim Results from Ongoing Phase 1b/2 Clinical Trial of Cavrotolimod (AST-008)
From Exicure, Inc.
Via Business Wire
Exicure, Inc. to Present at the BTIG Virtual Biotechnology Conference
From Exicure, Inc.
Via Business Wire
Ipsen and Exicure Enter Into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
From Ipsen and Exicure, Inc.
Via Business Wire
Exicure Announces Upcoming Neuroscience Pipeline Update at Virtual R&D Day
From Exicure, Inc.
Via Business Wire
Exicure, Inc. to Present at Ladenburg Thalmann 2021 Healthcare Conference
From Exicure, Inc.
Via Business Wire
Exicure, Inc. Announces Participation in Upcoming Conferences
From Exicure, Inc.
Via Business Wire
Exicure Announces Appointment of Brian C. Bock as Chief Financial Officer (CFO)
From Exicure, Inc.®
Via Business Wire
Exicure, Inc. Reports First Quarter 2021 Financial Results and Corporate Progress
From Exicure, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.